Kostas Biliouris

Stock Analyst at BMO Capital

(0)
# 4573
Out of 5,231 analysts
51
Total ratings
23.81%
Success rate
-14.95%
Average return
Main Sectors:
Top Industries:
18 Stocks
Name Action Price Target Current % Upside Ratings Updated
Intellia Therapeutic...
Maintains: Outperform
70 50
10.15 392.61% 6 Jan 10, 2025
Precision BioScience...
Upgrades: Outperform
34 34
4.97 584.1% 3 Jan 10, 2025
Centessa Pharmaceuti...
Maintains: Outperform
20 35
16.95 106.49% 6 Sep 16, 2024
Metagenomi
Maintains: Outperform
22 17
2.64 543.94% 2 Aug 15, 2024
Ionis Pharmaceutical...
Downgrades: Market Perform
67 60
32.85 82.65% 1 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
63 40
5.01 698.4% 4 Jul 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 90
36.03 149.79% 3 Jul 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
234 234
274.02 -14.6% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
170 200
115.53 73.12% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
120 120
33.16 261.88% 3 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
57
25.95 119.65% 3 Mar 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
37
36.42 1.59% 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
67
5.22 1183.52% 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
102 100
63.48 57.53% 4 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
19
2.76 588.41% 1 Oct 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
98 49
n/a n/a 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 62
7.7 705.19% 2 Jul 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
98
41.25 137.58% 1 Jun 17, 2022